These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31551131)

  • 1. CRISPR-Cas systems ushered in an era of facile DNA-free genome editing.
    Ajay J; Vandna R
    Semin Cell Dev Biol; 2019 Dec; 96():1-3. PubMed ID: 31551131
    [No Abstract]   [Full Text] [Related]  

  • 2. CRISPR-Cas immunity, DNA repair and genome stability.
    Cubbon A; Ivancic-Bace I; Bolt EL
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30209206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Gene Manipulation in Plants Using the CRISPR/Cas Technology.
    Zhang D; Li Z; Li JF
    J Genet Genomics; 2016 May; 43(5):251-62. PubMed ID: 27165865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing the native type I-B CRISPR-Cas for genome editing in a polyploid archaeon.
    Cheng F; Gong L; Zhao D; Yang H; Zhou J; Li M; Xiang H
    J Genet Genomics; 2017 Nov; 44(11):541-548. PubMed ID: 29169919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR/Cas: An intriguing genomic editing tool with prospects in treating neurodegenerative diseases.
    Rahman S; Datta M; Kim J; Jan AT
    Semin Cell Dev Biol; 2019 Dec; 96():22-31. PubMed ID: 31102655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Editing With TALEN and CRISPR/Cas in Rice.
    Bi H; Yang B
    Prog Mol Biol Transl Sci; 2017; 149():81-98. PubMed ID: 28712502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress of CRISPR-Cas Based Genome Editing in Photosynthetic Microbes.
    Naduthodi MIS; Barbosa MJ; van der Oost J
    Biotechnol J; 2018 Sep; 13(9):e1700591. PubMed ID: 29396999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and applications of Type I CRISPR-Cas systems.
    Hidalgo-Cantabrana C; Barrangou R
    Biochem Soc Trans; 2020 Feb; 48(1):15-23. PubMed ID: 31922192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. As CRISPR-Cas adoption soars, summit calls for genome editing oversight.
    Smalley E
    Nat Biotechnol; 2018 Jun; 36(6):485. PubMed ID: 29874214
    [No Abstract]   [Full Text] [Related]  

  • 10. On the Origin of CRISPR-Cas Technology: From Prokaryotes to Mammals.
    Mojica FJM; Montoliu L
    Trends Microbiol; 2016 Oct; 24(10):811-820. PubMed ID: 27401123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Methods of Evaluating the Efficiency of CRISPR/Cas Genome Editing].
    Lomov NA; Viushkov VS; Petrenko AP; Syrkina MS; Rubtsov MA
    Mol Biol (Mosk); 2019; 53(6):982-997. PubMed ID: 31876277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome editing: progress and challenges for medical applications.
    Carroll D
    Genome Med; 2016 Nov; 8(1):120. PubMed ID: 27846896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing heterologous and endogenous CRISPR-Cas machineries for efficient markerless genome editing in Clostridium.
    Pyne ME; Bruder MR; Moo-Young M; Chung DA; Chou CP
    Sci Rep; 2016 May; 6():25666. PubMed ID: 27157668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid Control of Genome Editing in Human Cells by Chemical-Inducible CRISPR-Cas Systems.
    Liu KI; Ramli MNB; Sutrisnoh NB; Tan MH
    Methods Mol Biol; 2018; 1772():267-288. PubMed ID: 29754234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harnessing Type I and Type III CRISPR-Cas systems for genome editing.
    Li Y; Pan S; Zhang Y; Ren M; Feng M; Peng N; Chen L; Liang YX; She Q
    Nucleic Acids Res; 2016 Feb; 44(4):e34. PubMed ID: 26467477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CRISPR/Cas9 Genome Editing Revolution.
    Jiao R; Gao C
    J Genet Genomics; 2016 May; 43(5):227-8. PubMed ID: 27256542
    [No Abstract]   [Full Text] [Related]  

  • 17. Temperature effect on CRISPR-Cas9 mediated genome editing.
    Xiang G; Zhang X; An C; Cheng C; Wang H
    J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9-Based Genome Editing in Plants.
    Zhang Y; Ma X; Xie X; Liu YG
    Prog Mol Biol Transl Sci; 2017; 149():133-150. PubMed ID: 28712494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The CRISPR/Cas system: a genome editing tool to develop animal models of viral infections].
    Castino G; Guillemet M; Joly A; Vignon A
    Med Sci (Paris); 2018 May; 34(5):403-405. PubMed ID: 29900841
    [No Abstract]   [Full Text] [Related]  

  • 20. CRISPR-Enabled Tools for Engineering Microbial Genomes and Phenotypes.
    Tarasava K; Oh EJ; Eckert CA; Gill RT
    Biotechnol J; 2018 Sep; 13(9):e1700586. PubMed ID: 29917318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.